Extra- and intracellular action of quaternary devapamil on muscle L-type Ca2+-channels

British Journal of Pharmacology

Volumn 119, Issue 6, 1996, Pages 1197-1202

  Berjukov, Stanislav ^a   Aczel, Stefan ^a   Beyer, Barbara ^b   Kimball, S David ^b   Dichtl, Manfred ^a   Hering, Steffen ^a   Striessnig, Jörg ^a  

^a A 6020   (Austria)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

A7r5 cells; Benzothiazepine receptor; Ca2+ channels; Phenylalkylamine receptor; Quaternary devapamil

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DEVAPAMIL; PHENYLALKYLAMINE; SODIUM ION; STRONTIUM; VERAPAMIL DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ION CURRENT; PATCH CLAMP; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SODIUM CURRENT;

EID: 0029949713     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16022.x     Document Type: Article

References (32)

1. ADACHI-AKAHANE, S., AMANO, Y., OKUYAMA, R. & NAGAO, T. (1993). Quaternary diltiazem can act from both sides of the membrane in ventricular myocytes. Jpn. J. Pharmacol., 61, 263-266.
2. CATTERALL, W.A. & STRIESSNIG, J. (1992). Receptor sites for calcium antagonists. Trends Pharmacol. Sci., 13, 256-262.
3. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
4. DELEAN, A., MUNSON P.J., & RODBARD D. (1978). Simultaneous analysis of families of sigmoid curves: application to bioassays, radioligand assay and physiological dose-response curves. Am. J. Physiol., 4, E91-E102.
5. 1A (BI). J. Biol. Chem.,271, 11745-11749.
6. GLOSSMANN, H. & FERRY. D.R. (1985). Assay for calcium channels. Methods Enzymol., 109, 513-550.
7. GLOSSMANN, H. & STRIESSNIG, J. (1990). Molecular properties of calcium channels. Rev. Physiol. Biochem. Pharmacol., 114, 1-105.
8. 2+ channels labelled with [3H]verapamil. Eur. J. Biochem., 141, 177-186.
9. 2+ channel probe: binding characteristics and target size analysis of its receptor in skeletal muscle. FEBS Lett., 176, 371-377.
10. HAMILL, O.P., MARTY A., NEHER E., SAKMANN B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high-resolution recording from cell and cell-free membrane patches. Pflügers Arch., 391, 85-100.
11. HERING, S., BOLTON T.B., BEECH D.J. & LIM, S.P. (1989). Mechanism of calcium channel block by D600 in single smooth muscle cells from rabbit ear artery. Circ. Res., 64, 928-936.
12. HERING, S., SAVCHENKO A., STRÜBING C., LAKITSCH M. & STRIESSNIG, J. (1993). Extracellular localization of the benzothiazepine binding domain of L-type calcium channels. Mol. Pharmacol., 43, 820-826.
13. HERING, S. & TIMIN, E.N. (1993). Estimation of drug affinities for calcium channel conformational states. In Molecular and Cellular Biology of Pharmacological Targets ed. Glossmann, H. & Striessnig, J. New York: Plenum Press.
14. HESCHELER, J., PELZER D., TRUBE G. & TRAUTWEIN, W. (1982). Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane. Pflügers Arch., 393, 287-291.
15. HILLE, B. (1991). Ionic Channels of Excitable Membranes. 2nd Ed. Sunderland: Sinauer.
16. HOCKERMAN, G.H., JOHNSON, B.D., SCHEUER, T. & CATTERALL, W.A. (1995). Molecular determinants of high affinity phenylalkylamine block of L-type calcium channels. J. Biol. Chem., 270, 22119-22122.
17. KASS, R.S., ARENA J.P. & CHIN S.(1991). Block of L-type calcium channels by charged dihydropyridines. J. Gen. Physiol., 98, 63-75.
18. KIMBALL, S.D., FLOYD D.M., DAS J., KRAPCHO J., HUNT J.T., ROVNIAK G., DUFF K.J., LEE V.G., MOQUIN R.V., TURK C.F., HEGBERG S.A., MORELAND S., BRITTAIN R.J., MCMULLEN D.M., NORMANDIN D.E. & CUCINOTTA J.C. (1992). Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site. J. Med. Chem., 35, 780-793.
19. KIMBALL, S D., J.T. HUNT, J.C. BARRISH, J. DAS, D.M. FLOYD, M.W. LAGO, V.G. LEE, S.H. SPERGEL, S. MORELAND, A. HEDBERG, J.Z. GOUGOUTAS, M.F. MALLEY & LAU, W.F. (1993). 1-Benzazepin-2-one calcium channel blockers-VI. Receptor-binding model and possible relationship to desmethoxyverapamil. Bioorg. Med. Chem., 1, 285-307.
20. 3 subunit. FEBS Lett., 373, 103-107.
21. 2+ channel in vascular smooth muscle cells: comparison with permanently charged derivative, D890. Am. J. Physiol., 257, 689-695.
22. LEE, K.S. & TSIEN, R.W. (1983). Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature, 302, 790-794.
23. MANNHOLD, R., RODENKIRCHEN R. & BAYER, R. (1982). Qualitative and quantitative structure-activity relationships of specific Ca antagonists. Pharmacology, 5, 26-49.
24. MILLER, R.J. (1992). Voltage-sensitive Ca2 + channels. J. Biol. Chem., 267, 1403-1406.
25. REYNOLDS, I.J., SNOWMAN A.M. & SNYDER, S.H. (1986). (-)-[3H]desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation ,by temperature and dihydropyridines. J. Pharmacol. Exp. Ther., 237, 731-738.
26. SAVCHENKO A., GLOSSMANN H. & HERING S. (1995). Improved micro-perfusion chamber for multiple and rapid solution exchange in adherent single cells Pflügers Arch. 429, 436-442.
27. SEYDL, K., KIMBALL D., SCHINDLER H. & ROMANIN, C. (1993). The benzazepinone/benzothiazepine binding site of the cardiac L-type calcium channel is accessible from the extracellular side. Pflügers Arch., 424, 552-554.
28. 2+ channels in excitable tissues. Cell Physiol. Biochem., 3, 295-317.
29. STRIESSNIG, J , GOLL A , MOOSBURGER K. & GLOSSMANN, H. (1986). Purified calcium channels have three allosterically coupled drug receptors. FEBS Lett., 197, 204-210.
30. STRIESSNIG, J., KNAUS H.-G., GRABNER M., MOOSBURGER K., SEITZ W., LIETZ H. & GLOSSMANN H.. (1987). Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. FEBS Lett., 212, 247-253.
31. WEGENER, J.W. & NAWRATH, H. (1995). Extracellular site of action of phenylalkylamines on L-type calcium current in rat ventricular myocytes. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 322-330.
32. 2+ channel blockers. Eur. J. Pharmacol., 130, 243-248.